Results 101 to 110 of about 2,272 (175)

Efficacy and Safety of Eravacycline Combination Therapy for Carbapenem-Resistant Acinetobacter baumannii Pneumonia in ICU Patients: A Retrospective Study

Infection and Drug Resistance
Qingli Guo,1,* Yifei Wei,2,* Qiongrui Zhao,3 Wenping Zhang,4 Pin Lv,5 Zhimin Zhou,1 Shanmei Wang6 1Department of Clinical Laboratory, Xuchang People’s Hospital, Xuchang, Henan, People’s Republic of China; 2Department of Clinical ...
Guo Q, Wei Y, Zhao Q, Zhang W, Lv P, Zhou Z, Wang S   +6 more
doaj  

Screening and comparison of in vitro-induced resistant and clinically resistant Stenotrophomonas maltophilia strains for eravacycline resistance-related genes

Frontiers in Cellular and Infection Microbiology
ObjectiveTo identify genes related to eravacycline resistance in Stenotrophomonas maltophilia (Sm) and to provide a theoretical basis for the study of eravacycline resistance mechanisms in Sm and the development of new antibiotics.MethodsThe study ...
Jie Wu, Jiarong Song, Junchang Cui
doaj   +1 more source

Gastrointestinal risk profile of tigecycline, omadacycline and eravacycline: Evidence from the FDA adverse event reporting system

Acta Pharmaceutica
This study assessed the gastrointestinal (GI) safety profiles of tigecycline, omadacycline, and eravacycline through a retrospective disproportionality analysis of reports submitted to the FDA Adverse Event Reporting System (FAERS) between the second ...
Wang Zhu, Gan Guoping, Yao Haiping
doaj   +1 more source

Emergence of plasmid-borne tet(X4) resistance gene in clinical isolate of eravacycline- and omadacycline-resistant Klebsiella pneumoniae ST485

Microbiology Spectrum
Omadacycline and eravacycline are gradually being used as new tetracycline antibiotics for the clinical treatment of Gram-negative pathogens. Affected by various tetracycline-inactivating enzymes, there have been reports of resistance to eravacycline and
Xiaojing Liu, Yi Liu, Xiaohan Ma, Ruyan Chen, Chenyu Li, Hongxin Fu, Yu Yang, Kexin Guo, Xiaoping Zhang, Ruishan Liu, Hao Xu, Junfei Zhu, Beiwen Zheng   +12 more
doaj   +1 more source

Eravacycline: from clinical trials to its potential place in everyday therapy

Purpose of review – The ongoing emergence of multidrug-resistant (MDR) pathogens represents a major challenge in clinical practice, highlighting the need of novel antimicrobial agents.
Castaldo, Nadia, Fantin, Alberto, Vena, Antonio, Taramasso, Lucia, Bassetti, Matteo, Giacobbe, Daniele Roberto   +5 more
core   +1 more source

The Efficacy and Safety of Eravacycline in the Treatment of Complicated Intra-Abdominal Infections: A Systemic Review and Meta-Analysis of Randomized Controlled Trials

, 2019
This study aims to assess the clinical efficacy and safety of eravacycline for treating complicated intra-abdominal infection (cIAI) in adult patients.
Shao-Huan Lan, Chien-Ming Chao, Li-Chin Lu, Chih-Cheng Lai, Shen-Peng Chang   +4 more
core   +1 more source

Synthesis of Eravacycline [PDF]

Synfacts, 2013
openaire   +1 more source

Pharmacokinetic/pharmacodynamic target attainment of eravacycline in a liver transplant recipient with refractory VRE <i>faecium</i> infection. [PDF]

Antimicrob Agents Chemother
Chen G, Dai Y, Qu Q, Xiao Y, Wang F, Qu J.   +5 more
europepmc   +1 more source

Beyond β-Lactams: Defining the Role of Eravacycline in Multidrug-Resistant and Metallo-β-Lactamase-Producing Infections. [PDF]

Antibiotics (Basel)
Keck JM.
europepmc   +1 more source

<i>In vitro</i> activity of eravacycline and comparator agents against Gram-negative and Gram-positive bacteria: results from China Antimicrobial Surveillance Network between 2017 and 2019. [PDF]

JAC Antimicrob Resist
Ou H, Yang Y, Shen S, Ding L, Yin D, Han R, Hu F.   +6 more
europepmc   +1 more source